OR WAIT null SECS
July 06, 2026
Article
Catch up on key FDA approvals, major trial updates, and critical clinician insights from the last 6 months.
July 01, 2026
Catch up on FDA approvals, trial readouts, and key clinician insights across the cardiology specialty.
June 02, 2026
May 2026 saw substantial FDA decisions, major trial results, guideline updates, and more.
June 01, 2026
FDA accepted a priority review sNDA for mavacamten in adolescents with symptomatic obstructive hypertrophic cardiomyopathy.
May 08, 2026
Video
Ahmad Masri, MD, from OHSU, discusses the positive topline results from this phase 3 trial, highlighting a new path forward for nHCM.
May 04, 2026
April 2026 saw further updates from ACC.26, plus key trial results, guideline updates, and more.
April 28, 2026
The FDA granted Fast Track Designation to coramitug, an investigational anti-TTR antibody designed to clear existing amyloid deposits in ATTR cardiomyopathy.
April 14, 2026
Blood discusses his recent study of the RECTIFIER AI model, highlighting its superior sensitivity and accuracy compared to physicians.
April 09, 2026
Catch up on major trial results, groundbreaking guideline updates, and more.
April 06, 2026
Catch up on data from some of the most impactful trials presented at the American College of Cardiology 2026.
